# Transformation of Classical Hodgkin Lymphoma Into Non-Hodgkin Lymphoma: Three Case Reports From the West Bank

**Authors:** Mohammed B. Abboushi, Omar Marouf, Mohammed AbuBaha, Hossam Salameh, Ro'ya Soradi, Riad Ahmad Amer

PMC · DOI: 10.1155/crom/4802098 · Case Reports in Oncological Medicine · 2025-10-29

## TL;DR

This paper reports three rare cases where classical Hodgkin lymphoma transformed into non-Hodgkin lymphoma, emphasizing the need for repeat biopsies and highlighting the clinical challenges.

## Contribution

The paper presents the first reported cases of Hodgkin lymphoma transformation from Palestine and adds to the limited global literature on this phenomenon.

## Key findings

- Transformation occurred after treatment or at initial diagnosis, showing varied clinical courses.
- Histopathological confirmation through repeat biopsy was crucial for accurate diagnosis.
- Outcomes ranged from progressive disease to indolent recurrence, requiring diverse treatment approaches.

## Abstract

Classical Hodgkin lymphoma (cHL) is a highly curable B-cell malignancy; though, rarely, it can transform into non-Hodgkin lymphoma (NHL), including diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, or marginal zone lymphoma. Reports of such transformations remain limited in the literature.

The aim of this study is to describe the clinical course, histopathological findings, and outcomes of three patients with cHL who developed secondary NHL.

Case 1 involved transformation from cHL to CD20+/CD30+ DLBCL following multiple lines of chemotherapy and autologous stem cell transplant, eventually resulting in progressive disease and death. Case 2 transformed into follicular lymphoma Grade 3a more than a year after cHL remission, with marrow infiltration managed conservatively pending systemic therapy. Case 3 presented with composite lymphoma at diagnosis (cHL and extranodal marginal zone lymphoma) and experienced indolent but recurrent disease involving the liver, requiring multiple rounds of chemoimmunotherapy.

Transformation of cHL into NHL, though rare, may occur years after initial treatment or concurrently at presentation. These cases underscore the importance of repeat biopsy in suspected relapses and highlight the clinical and pathological heterogeneity of such transformations. Our paper adds to the limited literature on this phenomenon and is the first of its kind reported from Palestine.

## Linked entities

- **Proteins:** MS4A1 (membrane spanning 4-domains A1), TNFRSF8 (TNF receptor superfamily member 8)
- **Diseases:** Classical Hodgkin lymphoma (MONDO:0009348), non-Hodgkin lymphoma (MONDO:0018908), diffuse large B-cell lymphoma (MONDO:0018905), follicular lymphoma (MONDO:0018906), marginal zone lymphoma (MONDO:0017604)

## Full-text entities

- **Genes:** KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, TNFRSF8 (TNF receptor superfamily member 8) [NCBI Gene 943] {aka CD30, D1S166E, Ki-1}
- **Diseases:** extranodal marginal zone lymphoma (MESH:D018442), follicular lymphoma (MESH:D008224), death (MESH:D003643), NHL (MESH:D008228), Classical Hodgkin Lymphoma (MESH:D006689), lymphoma (MESH:D008223), DLBCL (MESH:D016403), B-cell malignancy (MESH:D016393)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12588754/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12588754/full.md

## References

8 references — full list in the complete paper: https://tomesphere.com/paper/PMC12588754/full.md

---
Source: https://tomesphere.com/paper/PMC12588754